Latest Regulatory News

Page 673 of 744
Tivan Limited has formalised a Resourcing Protocol Agreement with the Kimberley Land Council, setting a clear path to negotiate an Indigenous Land Use Agreement for its Speewah Project.
Maxwell Dee
Maxwell Dee
14 Feb 2025
Suvo Strategic Minerals has extended its key take or pay Offtake Agreement with Chaozhou Chengcheng Industrial Co., Ltd, increasing minimum hydrous kaolin order volumes by 25% over five years, valued at approximately A$6.56 million.
Maxwell Dee
Maxwell Dee
14 Feb 2025
Global Lithium Resources Limited has refreshed its board following the 2025 AGM, appointing Dr Dianmin Chen as Managing Director and CEO to spearhead strategic milestones at the Manna Lithium Project and restore investor confidence.
Maxwell Dee
Maxwell Dee
14 Feb 2025
FireFly Metals Ltd reported a reduced half-year loss of A$5.7 million for December 2024, bolstered by a significant increase in cash reserves and strategic asset acquisitions in Canada and Australia.
Maxwell Dee
Maxwell Dee
14 Feb 2025
AMP Limited’s FY24 Data Pack outlines a solid underlying profit performance despite headwinds, with key insights into its banking, platform, and wealth management divisions.
Claire Turing
Claire Turing
14 Feb 2025
AMP Limited’s 2024 results reveal a 43% drop in statutory net profit to $150 million, offset by a 15.1% rise in underlying profit to $236 million, alongside the completion of its Advice business sale and the launch of a new digital bank.
Claire Turing
Claire Turing
14 Feb 2025
GQG Partners Inc. has announced a quarterly ordinary dividend of USD 0.0378 per CDI, payable on March 27, 2025, with an option for Australian dollar conversion at a specified exchange rate.
Claire Turing
Claire Turing
14 Feb 2025
AVITA Medical reported a strong 30% increase in Q4 2024 commercial revenue and amended its credit agreement with OrbiMed to adjust revenue covenants through 2026. The company is poised for significant growth with new product rollouts and expects profitability by year-end 2025.
Ada Torres
Ada Torres
14 Feb 2025
AVITA Medical's Q4 2024 earnings reveal strong commercial growth alongside the launch of Cohealyx, a novel collagen-based skin substitute that promises to transform acute wound care.
Ada Torres
Ada Torres
14 Feb 2025
AVITA Medical reported a robust 30% increase in Q4 2024 commercial revenue alongside key FDA clearances, setting the stage for ambitious growth in 2025.
Ada Torres
Ada Torres
14 Feb 2025
Ragnar Metals has identified multiple large conductive anomalies at its Viken Project in Sweden, reinforcing the potential for significant uranium, vanadium, and molybdenum mineralisation. These findings, derived from reprocessed VLF geophysics and historical drilling data, set the stage for targeted exploration.
Maxwell Dee
Maxwell Dee
14 Feb 2025
Cochlear Limited posted a 6% increase in HY25 sales revenue driven by strong implant sales but anticipates FY25 profits at the lower end of guidance due to declining services revenue and rising cloud investments.
Ada Torres
Ada Torres
14 Feb 2025